Yayın:
Are the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorEren Gündüz
dc.contributor.authorOlga Meltem Akay
dc.contributor.authorCengiz Bal
dc.contributor.authorZafer Gülbaş
dc.contributor.orcid0000-0002-4434-4580
dc.contributor.orcid0000-0002-6759-1939
dc.contributor.orcid0000-0002-1553-2902
dc.contributor.orcid0000-0002-4709-0627
dc.date.accessioned2025-11-13T10:42:22Z
dc.date.issued2015-03-05
dc.identifier.doi10.4274/tjh.2013.0325
dc.identifier.endpage28
dc.identifier.issn1300-7777
dc.identifier.issue1
dc.identifier.openalexW2078853987
dc.identifier.startpage21
dc.identifier.urihttps://hdl.handle.net/11421/5008
dc.identifier.urihttps://doi.org/10.4274/tjh.2013.0325
dc.identifier.volume32
dc.language.isoen
dc.relation.ispartofTurkish Journal of Hematology
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectVascular endothelial growth factor
dc.subjectInternational Prognostic Index
dc.subjectLymphoma
dc.subjectErythrocyte sedimentation rate
dc.subjectOncology
dc.subjectInterleukin 6
dc.subjectPopulation
dc.subjectCytokine
dc.subjectGastroenterology
dc.subjectVEGF receptors
dc.subjectRituximab
dc.titleAre the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients?
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5058571002

Dosyalar

Koleksiyonlar

Publications